A Pilot Study of Pivanex in Patients With Chronic Lymphocytic Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00083473
Recruitment Status : Terminated
First Posted : May 26, 2004
Last Update Posted : August 30, 2005
Information provided by:
Titan Pharmaceuticals

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Primary Completion Date : No date given
  Study Completion Date : April 2005